Lv1
40 积分 2021-08-02 加入
ARID2 Loss Reprograms the Kynurenine-AhR Pathway to Restore Antitumor Immunity in CTNNB1-Mutant Hepatocellular Carcinoma
6天前
已完结
Landscape screening identifies the lactate-modifying enzyme AARS2 as a master regulator and therapeutic target in hepatocellular carcinoma
16天前
已完结
Glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors after liver resection for hepatocellular carcinoma in patients with type 2 diabetes: a target trial emulation study
1个月前
已完结
Norepinephrine promotes tumour cell aggressiveness and NK cell ferroptosis via ADRB2 in intrahepatic cholangiocarcinoma with perineural invasion
1个月前
已完结
Norepinephrine promotes tumour cell aggressiveness and NK cell ferroptosis via ADRB2 in intrahepatic cholangiocarcinoma with perineural invasion
1个月前
已完结
Spatiotemporal‐Controlled NIR‐II Immune Agonist Sensitizes Cancer Immunotherapy
2个月前
已完结
Targeting tumor-intrinsic STK40 induces immune vulnerability and drives T cell reinvigoration
3个月前
已完结
Effect of isoginkgetin on targeting methylenetetrahydrofolate dehydrogenase 2 to induce ROS-mediated apoptosis in non-small cell lung cancer
3个月前
已完结
An Inflammatory Checkpoint Generated by IL1RN Splicing Offers Therapeutic Opportunity for KRAS -Mutant Intrahepatic Cholangiocarcinoma
3个月前
已完结
Mutant KRAS and CK2 Cooperatively Stimulate SLC16A3 Activity to Drive Intrahepatic Cholangiocarcinoma Progression
3个月前
已完结
皖公网安备34019202002308
